Altimmune Statistics Share Statistics Altimmune has 81.11M
shares outstanding. The number of shares has increased by 14.12%
in one year.
Shares Outstanding 81.11M Shares Change (YoY) 14.12% Shares Change (QoQ) 5.32% Owned by Institutions (%) 50.48% Shares Floating 80.26M Failed to Deliver (FTD) Shares 9,836 FTD / Avg. Volume 0.17%
Short Selling Information The latest short interest is 28.1M, so 34.64% of the outstanding
shares have been sold short.
Short Interest 28.1M Short % of Shares Out 34.64% Short % of Float 34.91% Short Ratio (days to cover) 4.33
Valuation Ratios The PE ratio is -5.39 and the forward
PE ratio is -2.63.
Altimmune's PEG ratio is
0.28.
PE Ratio -5.39 Forward PE -2.63 PS Ratio 25596.73 Forward PS 45052.1 PB Ratio 4.14 P/FCF Ratio -6.41 PEG Ratio 0.28
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Altimmune.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.11,
with a Debt / Equity ratio of 0.01.
Current Ratio 13.11 Quick Ratio 13.11 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage -11463.56
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $338.98 Profits Per Employee $-1.61M Employee Count 59 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -45.66% in the
last 52 weeks. The beta is -0.01, so Altimmune's
price volatility has been lower than the market average.
Beta -0.01 52-Week Price Change -45.66% 50-Day Moving Average 4.93 200-Day Moving Average 6.15 Relative Strength Index (RSI) 33.1 Average Volume (20 Days) 5,689,316
Income Statement In the last 12 months, Altimmune had revenue of 20K
and earned -95.06M
in profits. Earnings per share was -1.34.
Revenue 20K Gross Profit 20K Operating Income -103.17M Net Income -95.06M EBITDA -94.81M EBIT -95.05M Earnings Per Share (EPS) -1.34
Full Income Statement Balance Sheet The company has 36.93M in cash and 1.68M in
debt, giving a net cash position of 35.24M.
Cash & Cash Equivalents 36.93M Total Debt 1.68M Net Cash 35.24M Retained Earnings -561.39M Total Assets 157.26M Working Capital 145.46M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -79.85M
and capital expenditures 0, giving a free cash flow of -79.85M.
Operating Cash Flow -79.85M Capital Expenditures n/a Free Cash Flow -79.85M FCF Per Share -1.12
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -515860% and -475295%.
Gross Margin 100% Operating Margin -515860% Pretax Margin -475295% Profit Margin -475295% EBITDA Margin -474060% EBIT Margin -515860% FCF Margin -399240%
Dividends & Yields ALT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ALT is $19,
which is 462.1% higher than the current price. The consensus rating is "Buy".
Price Target $19 Price Target Difference 462.1% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 14, 2018. It was a
backward
split with a ratio of 1:30.
Last Split Date Sep 14, 2018 Split Type backward Split Ratio 1:30
Scores Altman Z-Score 5.15 Piotroski F-Score 2
